H2020-JTI-IMI2-2016-10-two-stage

Suggested coordinators

Organisations that coordinated the most funded projects under this call.

• CEMM - FORSCHUNGSZENTRUM FUER MOLEKULARE MEDIZIN GMBH1 coordinated
• FONDAZIONE PENTA ETS1 coordinated
• EUROPEAN PATIENTS FORUM1 coordinated
• KING'S COLLEGE LONDON1 coordinated
• KTH1 coordinated
• UHEI1 coordinated
• EAU1 coordinated
• RADBOUDUMC1 coordinated

Strong partners

Frequent participants in this call’s funded projects (research, universities, public bodies, and mixed types).

• BAYER AKTIENGESELLSCHAFT6 projects · DE
• NOVARTIS5 projects · CH
• KING'S COLLEGE LONDON4 projects · UK
• RADBOUDUMC4 projects · NL
• ELI LILLY AND COMPANY LTD4 projects · UK
• JANSSEN PHARMACEUTICA NV4 projects · BE
• PFIZER4 projects · UK
• SARD4 projects · FR
• UOXF4 projects · UK
• UCB4 projects · BE

Industry partners

Companies and SMEs that appear often in this call’s historical projects.

• BAYER AKTIENGESELLSCHAFT6 projects · company
• NOVARTIS5 projects · company
• ELI LILLY AND COMPANY LTD4 projects · company
• JANSSEN PHARMACEUTICA NV4 projects · company
• PFIZER4 projects · company
• SARD4 projects · company
• UCB4 projects · company
• ROCHE3 projects · company
• GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED3 projects · company
• GRUNENTHAL GMBH2 projects · company
• IRIS2 projects · company
• COVANCE2 projects · company

Typical consortium size

Derived from historical funded projects linked to this call.

Partners per project

median 35 · avg 37.25

range 14 – 64 organisations

Country spread (sample)

18 countries

33–37 partner organisations (from median 35.0 in this call’s projects) · 18 countries appear often in the participant sample

Similar past projects

Largest EU contributions in this call — useful references for consortium patterns.

• c4c€67,000,000
• AIMS-2-TRIALS€54,999,999
• Hypo-RESOLVE€13,450,057
• ReSOLUTE€12,000,000
• IMI-PainCare€11,225,271
• PIONEER€6,000,000
• iConsensus€4,700,000
• PARADIGM€4,498,931